{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:49:22Z","timestamp":1793422162576,"version":"4.5.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5,1]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Patients may develop primary (congenital) or secondary (acquired) lymphedema, causing significant physical and psychosocial problems. To plan treatment for lymphedema and monitor a patient's progress, swelling, and problems in functioning associated with lymphedema development should be assessed at baseline and follow-up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>The purpose of this study was to investigate the reliability (test-retest, internal consistency, and measurement variability) and validity (content and construct) of data obtained with the Lymphoedema Functioning, Disability and Health Questionnaire for Lower Limb Lymphoedema (Lymph-ICF-LL).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>This was a multicenter, cross-sectional study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The Lymph-ICF-LL is a descriptive, evaluative tool containing 28 questions about impairments in function, activity limitations, and participation restrictions in patients with lower limb lymphedema. The questionnaire has 5 domains: physical function, mental function, general tasks\/household activities, mobility activities, and life domains\/social life. The reliability and validity of the Lymph-ICF-LL were examined in 30 participants with objective lower limb lymphedema.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Intraclass correlation coefficients for test-retest reliability ranged from .69 to .94, and Cronbach alpha coefficients for internal consistency ranged from .82 to .97. Measurement variability was acceptable (standard error of measurement=5.9\u201312.6). Content validity was good because all questions were understandable for 93% of participants, the scoring system (visual analog scale) was clear, and the questionnaire was comprehensive for 90% of participants. Construct validity was good. All hypotheses for assessing convergent validity and divergent validity were accepted.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Limitations<\/jats:title>\n                  <jats:p>The known-groups validity and responsiveness of the Dutch Lymph-ICF-LL and the cross-cultural validity of the English version of the Lymph-ICF-LL were not investigated.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The Lymph-ICF-LL is a Dutch questionnaire with evidence of reliability and validity for assessing impairments in function, activity limitations, and participation restrictions in people with primary or secondary lower limb lymphedema.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2522\/ptj.20130285","type":"journal-article","created":{"date-parts":[[2014,1,11]],"date-time":"2014-01-11T04:52:34Z","timestamp":1389415954000},"page":"705-721","source":"Crossref","is-referenced-by-count":69,"title":["Lymphoedema Functioning, Disability and Health Questionnaire for Lower Limb Lymphoedema (Lymph-ICF-LL): Reliability and Validity"],"prefix":"10.1093","volume":"94","author":[{"given":"Nele","family":"Devoogdt","sequence":"first","affiliation":[{"name":"N. Devoogdt, PT, PhD, Department of Rehabilitation Sciences, KU Leuven\u2013University of Leuven, Tervuursevest 101, Leuven, Belgium, and Leuven Lymphoedema Center, University Hospitals Leuven, Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"De Groef","sequence":"additional","affiliation":[{"name":"A. De Groef, PT, MSc, Department of Rehabilitation Sciences, KU Leuven\u2013University of Leuven, and Department of Physical Medicine and Rehabilitation, University Hospitals Leuven."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ad","family":"Hendrickx","sequence":"additional","affiliation":[{"name":"A. Hendrickx, PT, BSc, Expert Center for Lymphology, Nij Smellinghe Hospital, Drachten, the Netherlands."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Damstra","sequence":"additional","affiliation":[{"name":"R. Damstra, MD, PhD, Expert Center for Lymphology, Nij Smellinghe Hospital."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Christiaansen","sequence":"additional","affiliation":[{"name":"A. Christiaansen, PT, MSc, Department of Rehabilitation Sciences, KU Leuven\u2013University of Leuven, and Department of Physical Medicine and Rehabilitation, University Hospitals Leuven."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Geraerts","sequence":"additional","affiliation":[{"name":"I. Geraerts, PT, PhD, Department of Rehabilitation Sciences, KU Leuven\u2013University of Leuven, and Department of Physical Medicine and Rehabilitation, University Hospitals Leuven."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele","family":"Vervloesem","sequence":"additional","affiliation":[{"name":"N. Vervloesem, PT, MSc, Department of Rehabilitation Sciences, KU Leuven\u2013University of Leuven, and Department of Physical Medicine and Rehabilitation, University Hospitals Leuven."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignace","family":"Vergote","sequence":"additional","affiliation":[{"name":"I. Vergote, MD, PhD, Department of Gynecological Oncology, University Hospitals Leuven, and Leuven Cancer Institute, Leuven, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijke","family":"Van Kampen","sequence":"additional","affiliation":[{"name":"M. Van Kampen, PT, PhD, Department of Rehabilitation Sciences, KU Leuven\u2013University of Leuven, and Department of Physical Medicine and Rehabilitation, University Hospitals Leuven."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2019123007280462100_B1","first-page":"51","article-title":"The diagnosis and treatment of peripheral lymphedema: 2009 Concensus Document of the International Society of Lymphology","volume":"42","author":"International Society of Lymphology","year":"2009","journal-title":"Lymphology"},{"key":"2019123007280462100_B2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/1358836X9800300209","article-title":"Lymphedema: classification, diagnosis and therapy","volume":"3","author":"Szuba","year":"1998","journal-title":"Vasc Med"},{"key":"2019123007280462100_B3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1196\/annals.1413.014","article-title":"Estimating the population burden of lymphedema","volume":"1131","author":"Rockson","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"2019123007280462100_B4","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1742-4801.2005.00066.x","article-title":"Health-related quality of life with lymphoedema: a review of the literature","volume":"2","author":"Morgan","year":"2005","journal-title":"Int Wound J"},{"key":"2019123007280462100_B5","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1097\/01.NCC.0000281734.48479.33","article-title":"Lymphedema in gynecologic cancer survivors: an area for exploration?","volume":"30","author":"Lockwood-Rayermann","year":"2007","journal-title":"Cancer Nurs"},{"key":"2019123007280462100_B6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1191\/0269216305pm1020oa","article-title":"Lymphoedema: estimating the size of the problem","volume":"19","author":"Williams","year":"2005","journal-title":"Palliat Med"},{"key":"2019123007280462100_B7","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2458-11-S4-S3","article-title":"Use of the International Classification of Functioning, Disability and Health (ICF) as a conceptual framework and common language for disability statistics and health information systems","volume":"11","author":"Kostanjsek","year":"2011","journal-title":"BMC Public Health"},{"key":"2019123007280462100_B8","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2522\/ptj.20100087","article-title":"Lymphoedema Functioning, Disability and Health Questionnaire (Lymph-ICF): reliability and validity","volume":"91","author":"Devoogdt","year":"2011","journal-title":"Phys Ther"},{"key":"2019123007280462100_B9","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.3109\/09638288.2013.771710","article-title":"Coding of meaningful concepts in lymphedema-specific questionnaires with the ICF","volume":"35","author":"Viehoff","year":"2013","journal-title":"Disabil Rehabil"},{"key":"2019123007280462100_B10","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1743-6109.2006.00099.x","article-title":"Assessment of health-related quality of life in patients with lymphedema of the lower limb","volume":"14","author":"Franks","year":"2006","journal-title":"Wound Repair Regen"},{"key":"2019123007280462100_B11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7150\/ijms.7.353","article-title":"Primary lower limb lymphedema: a focus on its functional, social and emotional impact","volume":"7","author":"Symvoulakis","year":"2010","journal-title":"Int J Med Sci"},{"key":"2019123007280462100_B12","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1024\/0301-1526.34.1.31","article-title":"Development, validation and clinical use of the FLQA-I, a disease-specific quality of life questionnaire for patients with lymphedema","volume":"34","author":"Augustin","year":"2005","journal-title":"Vasa"},{"key":"2019123007280462100_B13","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/SLA.0b013e31817ed7c3","article-title":"Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis","volume":"248","author":"Spillane","year":"2008","journal-title":"Ann Surg"},{"key":"2019123007280462100_B14","first-page":"401","article-title":"A new device to measure upper limb circumferences: validity and reliability","volume":"29","author":"Devoogdt","year":"2010","journal-title":"Int Angiol"},{"key":"2019123007280462100_B15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2519\/jospt.2000.30.3.149","article-title":"Criterion-related validity of the figure-of-eight method of measuring ankle edema","volume":"30","author":"Mawdsley","year":"2000","journal-title":"J Orthop Sports Phys Ther"},{"key":"2019123007280462100_B16","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1097\/00007632-200012150-00008","article-title":"SF-36 health survey update","volume":"25","author":"Ware","year":"2000","journal-title":"Spine (Phila Pa 1976)"},{"key":"2019123007280462100_B17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1097\/01.phm.0000176452.17771.20","article-title":"How to assess the reliability of measurements in rehabilitation","volume":"84","author":"Lexell","year":"2005","journal-title":"Am J Phys Med Rehabil"},{"key":"2019123007280462100_B18","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1745-3984.1985.tb01065.x","article-title":"Face validity revisited","volume":"22","author":"Nevo","year":"1985","journal-title":"J Educ Meas"},{"key":"2019123007280462100_B19","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0895-4356(98)00086-9","article-title":"Methods for validating and norming translations of health status questionnaires: the IQOLA Project approach\u2014International Quality of Life Assessment","volume":"51","author":"Gandek","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"2019123007280462100_B20","volume-title":"The Design and Analysis of Clinical Experiments","author":"Fleiss","year":"1986"},{"key":"2019123007280462100_B21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1177\/082585970602200102","article-title":"Lower limb lymphedema: experiences and perceptions of cancer patients in the late palliative stage","volume":"22","author":"Frid","year":"2006","journal-title":"J Palliat Care"},{"key":"2019123007280462100_B22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1177\/082585970802400302","article-title":"The psychosocial effects of cancer-related lymphedema","volume":"24","author":"Towers","year":"2008","journal-title":"J Palliat Care"},{"key":"2019123007280462100_B23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/1049732306297660","article-title":"Experiences of living with non-cancer-related lymphedema: implications for clinical practice","volume":"17","author":"Bogan","year":"2007","journal-title":"Qual Health Res"},{"key":"2019123007280462100_B24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1188\/03.ONF.417-423","article-title":"The experience of lower limb lymphedema for women after treatment for gynecologic cancer","volume":"30","author":"Ryan","year":"2003","journal-title":"Oncol Nurs Forum"},{"key":"2019123007280462100_B25","volume-title":"International Classification of Functioning, Disability and Health: ICF","year":"2001"},{"key":"2019123007280462100_B26","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1023\/A:1026171315263","article-title":"Translating the Short-Form Headache Impact Test (HIT-6) in 27 countries: methodological and conceptual issues","volume":"12","author":"Gandek","year":"2003","journal-title":"Qual Life Res"},{"key":"2019123007280462100_B27","article-title":"Management of substance abuse. Process of translation and adaptation of instruments"},{"key":"2019123007280462100_B28","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0895-4356(98)00082-1","article-title":"Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment","volume":"51","author":"Bullinger","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"2019123007280462100_B29","volume-title":"Guidance for Industry: Patient-Reported Outcome Measures","author":"Food and Drug Administration","year":"2009"},{"key":"2019123007280462100_B30","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jclinepi.2010.02.006","article-title":"The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes","volume":"63","author":"Mokkink","year":"2010","journal-title":"J Clin Epidemiol"}],"container-title":["Physical Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ptj\/article-pdf\/94\/5\/705\/31635538\/ptj0705.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ptj\/article-pdf\/94\/5\/705\/31635538\/ptj0705.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,30]],"date-time":"2019-12-30T12:28:32Z","timestamp":1577708912000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ptj\/article\/94\/5\/705\/2735628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,1]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5,1]]}},"URL":"https:\/\/doi.org\/10.2522\/ptj.20130285","relation":{},"ISSN":["0031-9023","1538-6724"],"issn-type":[{"value":"0031-9023","type":"print"},{"value":"1538-6724","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,1]]}}}